FAVOR III China
et al. Lancet. 2021 Nov 3; S0140-6736(21)02248-0. doi: 10.1016/S0140-6736(21)02248-0.
FAVOR III Europe/Japan
Comparison of Quantitative Flow Ratio (QFR) and Conventional Pressure-wire Based Functional Evaluation for Guiding Coronary Intervention. A Randomized Clinical Non-inferiority Trial.
FAVOR IV-QVAS
Quantitative Flow Ratio (QFR) Guided Revascularization Strategy for Patients Undergoing Primary Valve Surgery With Comorbid Coronary Artery Disease.
公司 Company
大阳城集团娱乐APP网址
Shanghai Pulse Medical Technology, Inc.
LinkedIn: Pulse Medical
Twitter: @PulseMedTech
地址 Address
总部:上海市徐汇区宜山路900号1幢A6
联系我们 Contact us
Tel: 021-5467 0228
sales@pulse-imaging.com